Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.35 |
| ▸ | MAOB | P27338 | 3/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.34 |
| ▸ | SGK1 | O00141 | 4/20 | 0.33 |
| ▸ | MAT2A | P31153 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | AR | P10275 | 2/20 | 0.33 |
| ▸ | XDH | P47989 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20114509 | 0.94 | KDM4E (0.35) | MAOAMAOBSGK1MAT2AALDH1A1 | |
| SCHEMBL20150331 | 0.94 | ALDH1A1 (0.35) | MAOAMAOBCYP11B1CYP11B2MAT2A | |
| SCHEMBL20150296 | 0.93 | AR (0.39) | MAOAMAOBCYP11B1CYP11B2MAT2A | |
| SCHEMBL20150299 | 0.90 | AR (0.37) | CYP11B1CYP11B2MAT2AARXDH | |
| SCHEMBL20150315 | 0.90 | HSP90AB1 (0.32) | MAOAMAOBCYP11B1CYP11B2SGK1 | |
| SCHEMBL20150306 | 0.90 | AR (0.43) | CYP11B1CYP11B2ALDH1A1ARKDM4E | |
| SCHEMBL20114998 | 0.89 | KDM5B (0.35) | MAOAMAOBCYP11B1CYP11B2MAT2A | |
| SCHEMBL20114662 | 0.89 | PTGER4 (0.33) | CYP11B1CYP11B2SGK1MAT2AALDH1A1 | |
| SCHEMBL20150330 | 0.88 | MAT2A (0.36) | CYP11B1CYP11B2MAT2AALDH1A1KDM4E | |
| SCHEMBL20150324 | 0.88 | AR (0.36) | MAOAMAOBCYP11B1CYP11B2MAT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10421746-B2 | Organic molecules, especially for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2019-09-24 | — | — | US | disclosed |
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-17 | — | — | US | disclosed |
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, EPCAM, F12 | MAOA 579/4885MAOB 413/4885CYP11B1 1765/4885 |
| US-10421746-B2 | Organic molecules, especially for use in organic optoelectronic devices | OR10J3, EPCAM, F12 | MAOA 579/4885MAOB 413/4885CYP11B1 1765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.